A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine.
作者信息
Lavery M J, Nawimana S, Parslew R, Stewart L
机构信息
Department of Dermatology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.
Department of Dermatology, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, UK.
出版信息
Clin Exp Dermatol. 2021 Oct;46(7):1325-1327. doi: 10.1111/ced.14714. Epub 2021 May 25.
Abstract
摘要
相似文献
1
A flare of pre-existing erythema multiforme following BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine.接种BNT162b2（辉瑞-生物科技公司）新冠疫苗后，原有多形红斑病情复发。
Clin Exp Dermatol. 2021 Oct;46(7):1325-1327. doi: 10.1111/ced.14714. Epub 2021 May 25.
2
Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.口服多形红斑后 Pfizer-BioNTech COVID-19 疫苗接种：4 例报告。
BMC Oral Health. 2022 Mar 24;22(1):90. doi: 10.1186/s12903-022-02124-2.
3
Viral-like Reaction or Hypersensitivity? Erythema Multiforme Minor Reaction and Moderate Eosinophilia After the Pfizer-BioNTech BNT162b2 (mRNA-Based) SARS-CoV-2 Vaccine.病毒样反应还是超敏反应？辉瑞-生物科技公司BNT162b2（基于信使核糖核酸的）严重急性呼吸综合征冠状病毒2疫苗接种后的轻症多形红斑反应和中度嗜酸性粒细胞增多症
J Investig Allergol Clin Immunol. 2021 Feb 21;32(1):77-78. doi: 10.18176/jiaci.0757. Epub 2021 Sep 30.
4
Prompt onset of Rowell's syndrome following the first BNT162b2 SARS-CoV-2 vaccination.首次接种BNT162b2新冠疫苗后迅速出现罗威尔综合征。
J Eur Acad Dermatol Venereol. 2021 Jul;35(7):e415-e416. doi: 10.1111/jdv.17225. Epub 2021 Apr 19.
5
[Erythema multiforme following COVID-19 vaccination (BNT162b2)].[新型冠状病毒肺炎疫苗接种（BNT162b2）后出现的多形红斑]
Hautarzt. 2022 Jan;73(1):68-70. doi: 10.1007/s00105-021-04911-4. Epub 2021 Oct 21.
6
Atypical erythema multiforme related to BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine.与BNT162b2（辉瑞-生物科技公司）新冠疫苗相关的非典型多形红斑
Int J Dermatol. 2021 Nov;60(11):e466-e467. doi: 10.1111/ijd.15894. Epub 2021 Sep 2.
7
Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine.急性发热性嗜中性皮病、毛发红糠疹、急性痘疮样苔藓样糠疹和多形红斑的突然发作：揭示一个可能的共同触发因素——新冠疫苗。
Clin Exp Dermatol. 2022 Feb;47(2):437-440. doi: 10.1111/ced.14970. Epub 2021 Oct 21.
8
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
9
Erythema Multiforme Reactions Following Pfizer/BioNTech (Tozinameran) Vaccination: Two Case-Reports with Positive Rechallenge and Review of the Literature.辉瑞/生物新技术（Tozinameran）疫苗接种后的多形红斑反应：两例再挑战阳性病例报告及文献复习。
Curr Drug Saf. 2024;19(4):465-468. doi: 10.2174/1574886318666230725101846.
10
COVID-19 Updates: Pfizer-BioNTech COVID-19 vaccine.新冠疫情最新消息：辉瑞-生物科技公司新冠疫苗
Med Lett Drugs Ther. 2022 Jan 24;64(1642):16.
引用本文的文献
1
An Unusual Presentation of Erythema Multiforme Following the Administration of Pfizer-BioNTech COVID-19 mRNA Vaccine in a Pediatric Patient.一名儿科患者接种辉瑞-生物科技公司新冠mRNA疫苗后出现多形红斑的不寻常表现。
Cureus. 2024 Apr 17;16(4):e58450. doi: 10.7759/cureus.58450. eCollection 2024 Apr.
2
Increased prevalence of erythema multiforme in patients with COVID-19 infection or vaccination.新冠病毒感染或接种疫苗患者中多形红斑的患病率增加。
Sci Rep. 2024 Feb 2;14(1):2801. doi: 10.1038/s41598-024-52099-z.
3
Cases of Pernio-Like Lesions after mRNA-1273 Vaccination with Clinical and Pathological Features: A Single-Center Experience.mRNA-1273疫苗接种后出现具有临床和病理特征的冻疮样病变病例：单中心经验
Ann Dermatol. 2023 Nov;35(Suppl 2):S281-S286. doi: 10.5021/ad.21.307.
4
Occurrence of erythema multiforme following COVID-19 vaccination: a review.新型冠状病毒肺炎疫苗接种后多形红斑的发生情况：一项综述
Clin Exp Vaccine Res. 2023 Apr;12(2):87-96. doi: 10.7774/cevr.2023.12.2.87. Epub 2023 Apr 30.
5
Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis.新冠病毒疫苗接种后皮肤不良反应的全球流行率和临床表现：系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1947-1968. doi: 10.1111/jdv.18294. Epub 2022 Jun 21.
6
Erythema multiforme in a young adult following COVID-19 infection and vaccination in Tanzania.坦桑尼亚一名年轻成年人在感染 COVID-19 后接种疫苗，出现多形红斑。
BMJ Case Rep. 2022 May 23;15(5):e247168. doi: 10.1136/bcr-2021-247168.
7
IgA nephropathy relapse following COVID-19 vaccination treated with corticosteroid therapy: case report.COVID-19疫苗接种后IgA肾病复发，采用皮质类固醇治疗：病例报告
BMC Nephrol. 2022 Apr 7;23(1):135. doi: 10.1186/s12882-022-02769-9.
8
Cutaneous Complications of mRNA and AZD1222 COVID-19 Vaccines: A Worldwide Review.mRNA疫苗和AZD1222新冠疫苗的皮肤并发症：一项全球综述
Microorganisms. 2022 Mar 15;10(3):624. doi: 10.3390/microorganisms10030624.
9
Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.口服多形红斑后 Pfizer-BioNTech COVID-19 疫苗接种：4 例报告。
BMC Oral Health. 2022 Mar 24;22(1):90. doi: 10.1186/s12903-022-02124-2.
10
Erythema multiforme in COVID-19 patients and following COVID-19 vaccination: manifestations, associations and outcomes.新型冠状病毒肺炎患者及接种新型冠状病毒疫苗后的多形红斑：表现、关联因素及转归
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e524-e530. doi: 10.1111/jdv.18063. Epub 2022 Mar 21.
本文引用的文献
1
Cutaneous manifestations of COVID-19 in children (and adults): A virus that does not discriminate.儿童（和成人）中 COVID-19 的皮肤表现：一种不歧视的病毒。
Clin Dermatol. 2021 Mar-Apr;39(2):323-328. doi: 10.1016/j.clindermatol.2020.10.020. Epub 2020 Nov 1.
2
Erythema Multiforme: Recognition and Management.多形红斑：识别与管理。
Am Fam Physician. 2019 Jul 15;100(2):82-88.
3
Vaccine-induced toxic epidermal necrolysis: A case and systematic review.疫苗诱导的中毒性表皮坏死松解症：1例病例及系统综述
Dermatol Online J. 2018 Jan 15;24(1):13030/qt7qn5268s.
4
Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist.多形性红斑的临床特征、诊断和治疗：为皮肤科医生提供的实用综述。
Int J Dermatol. 2012 Aug;51(8):889-902. doi: 10.1111/j.1365-4632.2011.05348.x.
Zotero 插件